C. van Gulpen

582 total citations
11 papers, 444 citations indexed

About

C. van Gulpen is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, C. van Gulpen has authored 11 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Epidemiology and 2 papers in Infectious Diseases. Recurrent topics in C. van Gulpen's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Burn Injury Management and Outcomes (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). C. van Gulpen is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Burn Injury Management and Outcomes (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). C. van Gulpen collaborates with scholars based in Netherlands. C. van Gulpen's co-authors include Jaap T. van Dissel, Peter H. Nibbering, Mariena J. A. van der Plas, Gerrolt N. Jukema, Nicolle H. R. Litjens, Herman Mattie, E van Strijen, H. Mattie, Guido V. Bloemberg and Rik C. Schoemaker and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Drugs and British Journal of Clinical Pharmacology.

In The Last Decade

C. van Gulpen

10 papers receiving 414 citations

Peers

C. van Gulpen
Kap‐Sung Kim South Korea
Hyung Keun Kim South Korea
Ju Yuan China
Yuri Chaves Martins United States
Rina Su China
C. van Gulpen
Citations per year, relative to C. van Gulpen C. van Gulpen (= 1×) peers Kamaldeep Gill

Countries citing papers authored by C. van Gulpen

Since Specialization
Citations

This map shows the geographic impact of C. van Gulpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. van Gulpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. van Gulpen more than expected).

Fields of papers citing papers by C. van Gulpen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. van Gulpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. van Gulpen. The network helps show where C. van Gulpen may publish in the future.

Co-authorship network of co-authors of C. van Gulpen

This figure shows the co-authorship network connecting the top 25 collaborators of C. van Gulpen. A scholar is included among the top collaborators of C. van Gulpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. van Gulpen. C. van Gulpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Plas, Mariena J. A. van der, et al.. (2007). Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 61(1). 117–122. 124 indexed citations
2.
Plas, Mariena J. A. van der, Anne M. van der Does, Mara Baldry, et al.. (2007). Maggot excretions/secretions inhibit multiple neutrophil pro-inflammatory responses. Microbes and Infection. 9(4). 507–514. 73 indexed citations
3.
Does, Anne M. van der, Mara Baldry, C. van Gulpen, Jaap T. van Dissel, & Peter H. Nibbering. (2007). pro-inflammatory responses. 1 indexed citations
4.
Litjens, Nicolle H. R., Jacobus Burggraaf, E van Strijen, et al.. (2004). Pharmacokinetics of oral fumarates in healthy subjects. British Journal of Clinical Pharmacology. 58(4). 429–432. 119 indexed citations
5.
Litjens, Nicolle H. R., E van Strijen, C. van Gulpen, et al.. (2004). In vitro pharmacokinetics of anti-psoriatic fumaric acid esters. BMC Pharmacology. 4(1). 22–22. 55 indexed citations
6.
Overbosch, D., C. van Gulpen, J. Hermans, & H. Mattie. (1988). The effect of probenecid on the renal tubular excretion of benzylpenicillin.. British Journal of Clinical Pharmacology. 25(1). 51–58. 29 indexed citations
7.
Broek, P.J. van den, W. Bakker, H. Mattie, & C. van Gulpen. (1987). The use of cipfofloxacin in the treatment of patients with cystic fibrosis. Pharmacy World & Science. 9(S1). S68–S71. 1 indexed citations
8.
Gulpen, C. van, et al.. (1986). Determination of benzylpenicillin and probenecid in human body fluids by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 381(2). 365–372. 14 indexed citations
9.
Overbosch, D., C. van Gulpen, & H. Mattie. (1985). Renal Clearance of Temocillin in Volunteers1. Drugs. 29(Supplement 5). 128–134. 14 indexed citations
10.
Gulpen, C. van, et al.. (1985). Pharmacokinetics of vibunazole (BAY n 7133) administered orally to healthy subjects. Journal of Antimicrobial Chemotherapy. 16(1). 75–79. 7 indexed citations
11.
Mattie, H., B.A.C. Dijkmans, & C. van Gulpen. (1982). The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections. Journal of Antimicrobial Chemotherapy. 10(suppl A). 59–64. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026